These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 24191286

  • 1. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
    Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A.
    Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
    [Abstract] [Full Text] [Related]

  • 2. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L, Prisco S, Vanderriele PE, Lerco S, Torresan F, Maiolino G, Seccia TM, Iacobone M, Rossi GP.
    J Clin Endocrinol Metab; 2019 Sep 01; 104(9):3726-3734. PubMed ID: 30865228
    [Abstract] [Full Text] [Related]

  • 3. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH.
    Circ Res; 2015 Mar 13; 116(6):960-75. PubMed ID: 25767283
    [Abstract] [Full Text] [Related]

  • 4. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
    Brown J, de Boer IH, Robinson-Cohen C, Siscovick DS, Kestenbaum B, Allison M, Vaidya A.
    J Clin Endocrinol Metab; 2015 Feb 13; 100(2):490-9. PubMed ID: 25412416
    [Abstract] [Full Text] [Related]

  • 5. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.
    Brown JM, Vaidya A.
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun 13; 21(3):193-201. PubMed ID: 24694551
    [Abstract] [Full Text] [Related]

  • 6. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep 13; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.
    Expert Opin Pharmacother; 2007 Apr 13; 8(5):529-35. PubMed ID: 17376010
    [Abstract] [Full Text] [Related]

  • 8. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, März W, Pilz S.
    Metabolism; 2014 Jan 13; 63(1):20-31. PubMed ID: 24095631
    [Abstract] [Full Text] [Related]

  • 9. Interplay between sodium and calcium regulatory hormones: a clinically relevant research field.
    Tomaschitz A, Pilz S.
    Hypertension; 2014 Feb 13; 63(2):212-4. PubMed ID: 24191288
    [No Abstract] [Full Text] [Related]

  • 10. Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
    Bislev LS, Langagergaard Rødbro L, Nørgaard Bech J, Bjerregaard Pedersen E, Rolighed L, Sikjaer T, Rejnmark L.
    Clin Endocrinol (Oxf); 2018 Nov 13; 89(5):656-666. PubMed ID: 29733445
    [Abstract] [Full Text] [Related]

  • 11. The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.
    Zheng MH, Li FX, Xu F, Lin X, Wang Y, Xu QS, Guo B, Yuan LQ.
    Front Endocrinol (Lausanne); 2020 Nov 13; 11():539. PubMed ID: 32973674
    [Abstract] [Full Text] [Related]

  • 12. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
    Muller ME, Forni Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, Wuerzner G, Burnier M, Bonny O.
    Pflugers Arch; 2015 Dec 13; 467(12):2413-21. PubMed ID: 26089029
    [Abstract] [Full Text] [Related]

  • 13. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 14. Effects of truncated angiotensins in humans after double blockade of the renin system.
    Plovsing RR, Wamberg C, Sandgaard NC, Simonsen JA, Holstein-Rathlou NH, Hoilund-Carlsen PF, Bie P.
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov 02; 285(5):R981-91. PubMed ID: 12869368
    [Abstract] [Full Text] [Related]

  • 15. Renal response to captopril reflects state of local renin system in healthy humans.
    Fisher ND, Price DA, Litchfield WR, Williams GH, Hollenberg NK.
    Kidney Int; 1999 Aug 02; 56(2):635-41. PubMed ID: 10432403
    [Abstract] [Full Text] [Related]

  • 16. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway.
    Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH.
    Am J Physiol Heart Circ Physiol; 2010 Aug 02; 299(2):H422-30. PubMed ID: 20511409
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone stimulation by angiotensin II : influence of gender, plasma renin, and familial resemblance.
    Giacché M, Vuagnat A, Hunt SC, Hopkins PN, Fisher ND, Azizi M, Corvol P, Williams GH, Jeunemaitre X.
    Hypertension; 2000 Mar 02; 35(3):710-6. PubMed ID: 10720583
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN, Thorwald MA, Conte D, Vázquez-Medina JP, Nishiyama A, Ortiz RM.
    Clin Exp Pharmacol Physiol; 2015 Nov 02; 42(11):1178-88. PubMed ID: 26234762
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
    Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ.
    Hypertension; 2006 Dec 02; 48(6):1050-7. PubMed ID: 17043157
    [Abstract] [Full Text] [Related]

  • 20. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J.
    Clin Endocrinol (Oxf); 2002 Oct 02; 57(4):457-65. PubMed ID: 12354127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.